VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Activity

46 hedge funds and large institutions have $13.4M invested in VYNE Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+8
Holders Change %
+21.05%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAM
Cormorant Asset Management
Massachusetts
+$2.26M
2
KCM
Kennedy Capital Management
Missouri
+$942K
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$495K
4
IC
Ikarian Capital
Texas
+$479K
5
Jane Street
Jane Street
New York
+$206K

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$2.37M
2
EAM
Exome Asset Management
New York
-$419K
3
PHP
Parkman Healthcare Partners
Connecticut
-$344K
4
Renaissance Technologies
Renaissance Technologies
New York
-$173K
5
PCM
Prelude Capital Management
New York
-$127K
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
51
Virtu Financial
New York
– -$31K -19,574 Closed
SC
52
Shay Capital
New York
– -$28.5K -18,015 Closed
UBS Group
53
UBS Group
Switzerland
– -$12K -7,576 Closed
1 2
3